R&D spending of selected pharmaceutical firms in China 2023

Published by
Wenyi Zhang,
Nov 18, 2024

In 2023, China's leading innovative drug company Jiangsu Hengrui Pharmaceuticals spent 6.15 billion yuan on research and development. Pharmaceutical companies that focus on innovative drugs and therapies generally have a higher expenditure on research, while traditional Chinese medicine (TCM) companies often put more effort into marketing.

Research and development expenditure of selected pharmaceutical companies in China in 2023 (in billion yuan)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2024

Region

China

Survey time period

2023

Supplementary notes

One yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of November 2024).

Figures have been rounded for a better understanding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Jiangsu Hengrui Pharmaceuticals "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Jiangsu Hengrui Pharmaceuticals

Company positioning

6

Key company data

8

Research and development

5

Competitors

5

The oncology drug market

4

Further Content: You might find this interesting as well

Topics

Hengrui PharmaceuticalsMedical technology in ChinaPfizerJohnson & JohnsonPharmaceutical industry in Japan
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.